Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000834237-22-000811
Filing Date
2022-01-26
Accepted
2022-01-25 18:45:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 us71742q1067_012522.txt SC 13G 11554
  Complete submission text file 0000834237-22-000811.txt   13475
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Subject) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-88114 | Film No.: 22555181
SIC: 2834 Pharmaceutical Preparations

Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies